Table 2 Univariate Analysis of Outcomes Stratified by Sex-Specific HDL Quartiles.
From: Association between HDL levels and stroke outcomes in the Arab population
Sex-specific HDL cut-offs | Low HDL (n = 658) | Low-Normal HDL (n = 722) | High-Normal HDL (n = 309) | High HDL (n = 400) | p-value |
|---|---|---|---|---|---|
M: ≤ 0.80 F: ≤ 1.00 | M: 0.80–1.00 F: 1.00–1.30 | M: 1.00–1.12 F: 1.30–1.60 | M: > 1.12 F: > 1.60 | ||
Inpatient outcomes | |||||
LOS, d, median [IQR] | 4 [3–7] | 4 [2–6] | 4 [2–7] | 4 [2–6] | 0.045* |
In-hospital mortality, n (%) | 11 (1.7) | 8 (1.1) | 5 (1.6) | 10 (2.5) | 0.372 |
Thrombolysis, n (%) | 76 (11.6) | 67 (9.3) | 36 (11.7) | 34 (8.5) | 0.267 |
Thrombectomy, n (%) | 34 (5.2) | 19 (2.6) | 7 (2.3) | 11 (2.8) | 0.026* |
ICU admission, n (%) | 29 (4.4) | 28 (3.9) | 12 (3.9) | 18 (4.5) | 0.936 |
In-hospital complications, n (%) | 67 (10.2) | 63 (8.7) | 24 (7.8) | 36 (9.0) | 0.632 |
Post-discharge long-term outcomes | |||||
1-y stroke recurrence, n (%) | 36 (6.1) | 19 (2.9) | 8 (3.0) | 10 (2.9) | 0.014* |
mRS at 90 days, median [IQR] | 2 [0–3] | 1 [0–3] | 1 [0–3] | 1 [0–3] | 0.076 |
90-day mortality, n (%) | 26 (4.8) | 26 (4.4) | 11 (4.4) | 6 (1.9) | 0.209 |
1-y mortality, n (%) | 35 (5.9) | 38 (5.9) | 17 (6.3) | 9 (2.6) | 0.094 |
1-y post-stroke MACE, n (%) | 76 (11.7) | 61 (8.5) | 29 (9.5) | 24 (6.2) | 0.021* |
1-y post-stroke MI, n (%) | 7 (1.2) | 3 (0.5) | 1 (0.4) | Nil | 0.116 |
1-y post-stroke cardiac revascularization, n (%) | 4 (0.7) | 4 (0.6) | 3 (1.1) | 2 (0.6) | 0.844 |
